Please login (Members) to view content or
(Nonmembers) this article.
0

No votes yet

Novel Approaches

Tumor-Treating Fields: Nursing Implications for an Emerging Technology


Alice Chang
CJON 2017, 21(3), 302-304 DOI: 10.1188/17.CJON.302-304

Tumor-treating fields (TTFields) are a new technology used for cancer treatment consisting of battery-powered, insulated electromagnetic transducers that are placed on the scalp. This wearable, adhesive device is a certified physician-prescribed therapy for patients with glioblastoma multiforme, a type of primary brain cancer. TTFields are being used concomitantly with temozolomide (Temodar®) in patients with newly diagnosed glioblastoma and as a monotherapy in patients with recurrent glioblastoma after radiation therapy and chemotherapy. Nursing professionals caring for patients using this emerging technology should be able to educate patients regarding proper use of TTFields and monitor for side effects.


AT A GLANCE

  • TTFields are an innovative therapy currently used in the treatment of glioblastoma.
  • Patient education is essential to ensure correct use of the device and maximize efficacy of therapy.
  • Nursing professionals should routinely monitor for side effects associated with TTFields use by performing a focused physical assessment on patients undergoing treatment.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or